Dr. Kate D. Malliarakis
- Associate Professor; Chair of Policy, Populations and Systems Community; Interim Assistant Dean for DNP; Program Director of Executive Leadership
- Foggy Bottom Campus
- 1919 Pennsylvania Ave. NW
Washington, D.C. 20006
Kate Driscoll Malliarakis, PhD, ANP-BC, MAC, FAAN is an associate professor and the chair of the George Washington University School of Nursing (GW Nursing) Policy, Populations and Systems Community and the program director of DNP Executive Leadership track. Dr. Malliarakis' clinical interest is in substance abuse and addictions. Dr. Malliarakis maintains a private counseling practice specializing in addictions, especially health professionals with substance use disorders.
For over five years, Dr. Malliarakis was the Chief, Specific Drugs Branch in the White House Office of National Drug Control Policy in Washington, D.C., a policymaking office with direct oversight of more than 50 federal agencies that have received federal funds to address drug issues. After ONDCP, she served as a consultant for Fleishman-Hillard, a premier communications firm, where she worked principally on the White House Office of National Drug Control Policy’s National Youth Anti-Drug Media Campaign.
Dr. Malliarakis is a Robert Wood Johnson Executive Nurse Fellow currently serves as and serves on the transition committee for the RWJ ENF Alumni Association. She is a former board member of the Association of Association for Medical Education and Research in Substance Abuse (AMERSA) and currently is co-chair of AMERSA Nurses Special Interest Group. Dr. Malliarakis is a founding member and current Chair of the Committee on Impaired Nurses (COIN) for the District of Columbia Board of Nursing. She coauthored Substance use Disorders in Nursing: A Resource Manual and Guidelines for Alternative and Disciplinary Monitoring Programs for the National Council of State Boards of Nursing (NCSBN). In 2011, Dr. Malliarakis was awarded the Caron Foundation’s Medical Professionals Award for her work in the field of addictions and recovery. In 2014, Dr. Malliarakis was inducted as a Fellow in the American Academy of Nursing.
She is licensed and certified as an adult primary care nurse practitioner (ANP-BC) and master addictions counselor (MAC).
Impaired Nursing Practice/Alternative to Discipline Programs
Walden University, PhD, Health Sciences — 2012
- Specialty in Health and Human Behavior
Lesley University, Master of Science in Management — 1986
- Specialty in Substance Abuse Systems
University of Maryland, Adult Nurse Practitioner Certificate — 1976
Fitchburg State University, BSN — 1969
Malliarakis, K. (2015). Managing heroin addiction in an outpatient setting: A case study. Journal of Gerontological Nursing 41(12), 10-14.
Malliarakis, K. (2014, February). COIN Consult: DUIs—Why do they matter? DC Nurse, 11(1), 12.
Malliarakis, K. (2013, September). COIN Consult: When a CBC reveals driving under the influence (DUI). DC Nurse, 10(2), 12.
Darbro, N. & Malliarakis, K. (2012). Substance abuse: Risks factors and protective factors. Journal of Nursing Regulation, 3(1) 44-48.
Malliarakis, K., Smith, V., & Darbro, N. (2012). Regulatory management of substance use in high-risk nurse populations. Journal of Nursing Regulation 4(2), 32-39.
Malliarakis, K. (2012, May). COIN Consult: Workplace risk factors. DC Nurse, 9 (3), 12.
Darbro, N., Bainer, J., Dilling, T., Hoehn, K., Liddle, A., Malliarakis, K., et al. (2011). Substance use disorder in nursing: A resource manual and guidelines for alternative and disciplinary monitoring programs. Chicago, IL: National Council of State Boards of Nursing.
- Fellow of the American Academy of Nursing (2014)
- Caron Community Service Award (2011) Medical Professional Award
- Sigma Theta Tau Phi Epsilon Chapter (2011- ) Founding member
- Alpha Eta Honor Society (2007-2011), GW Honor Society (2008-2011)
- Fellow, Robert Wood Johnson Executive Nurse Leader Program: Member of the second cohort (1999) of 15 nurses chosen nationally for this three year Fellowship; past President of RWJF ENF Alumni Association
- 1998 Outstanding Performance Award: Appreciation and recognition for superior performance of official duties for the White House Office of National Drug Control Policy
- 1984 Distinguished Service Award: The National Academy of Sciences/National Research Council/Institute of Medicine